TDO2 and neoplasm: In pathology, TDO is expressed by tumor cells of all hepatocarcinomas and 25% of glioblastomas, as well as by pericytes of vascular structures in focal spots of most late stage tumors, and by pericytes in pulmonary inflammatory lesions (27, 28).